Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume

scientific article

Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3346/JKMS.2014.29.5.640
P932PMC publication ID4024948
P698PubMed publication ID24851018
P5875ResearchGate publication ID262539775

P50authorNam-Joon YiQ38544937
YoungRok ChoiQ49197691
Kyung-Suk SuhQ49468529
Kwang-Woong LeeQ57010951
Geun HongQ57010965
Min-Su ParkQ85905778
Hae Won LeeQ85905781
Suk-Won SuhQ87421989
Tae YooQ87421991
Myoung Hee ParkQ87926162
P2093author name stringKyungbun Lee
P2860cites workClassification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a surveyQ30004207
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodiesQ34206939
Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graftQ35911619
The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantationQ35975914
Humoral theory of transplantation: further evidenceQ36228533
Successful renal transplantation with desensitization in highly sensitized patients: a single center experienceQ37078119
Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantationQ37267474
The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.Q37644840
Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipientsQ37827197
Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologistQ37832763
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantationQ41343480
Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injuryQ42574211
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantationQ43683086
Positive T lymphocytotoxic cross-match in living donor liver transplantationQ44606831
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scoresQ44749306
Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejectionQ45061984
Comparative analysis of outcome following liver transplantation in US veteransQ45333555
Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantationQ46934550
Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's diseaseQ47199260
Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch.Q51016759
Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival.Q51765327
Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?Q53346777
Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume.Q53661718
Re-examination of the Lymphocytotoxic Crossmatch in Liver Transplantation: Can C4d Stains Help in Monitoring?Q62617379
Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantationQ73575601
Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantationQ79296636
C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody statusQ80308091
An artificial vascular graft is a useful interpositional material for drainage of the right anterior section in living donor liver transplantationQ80701865
Present status of ABO-incompatible living donor liver transplantation in JapanQ81422881
Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantationQ81604766
Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centreQ81813232
Human leukocyte antigen crossmatch testing is important for liver retransplantationQ83150370
Predictors of clinical outcome in children undergoing orthotopic liver transplantation for acute and chronic liver diseaseQ83898477
P433issue5
P921main subjectdesensitizationQ2700499
end-stage liver diseaseQ54974362
P304page(s)640-647
P577publication date2014-04-25
P1433published inJournal of Korean Medical ScienceQ24039955
P1476titlePreoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume
P478volume29

Reverse relations

cites work (P2860)
Q38907391Evaluation of donor workups and exclusions in a single-center experience of living donor liver transplantation.
Q35715908Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation
Q47148342Pretransplantation fetal-maternal microchimerism in pediatric liver transplantation from mother.

Search more.